Compared to BLM-treated wild type mice, BLM-treated PARK2 KO mice demonstrated enhanced lung fibrosis, which was evaluated by means of Masson trichrome staining and sircol collagen assay at day 21 (Fig. 5a, b). This evidence concerns the gene PRKN and pulmonary fibrosis.